[1]Fang TT,Sun XJ,Chen J,et al.Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential[J].Asian Pac J Cancer Prev,2015,15(23):10513-10524.
[2]Tarantino G,Magistri P,Ballarin R,et al.Oncological impact of m-tor inhibitor immunosuppressive therapy after liver transplantation for hepatocellular carcinoma:Review of the literature[J].Front Pharmacol,2016,7(1):387.
[3]Sepehri Z,Kiani Z,Kohan F,et al.Toll like receptor 4 and hepatocellular carcinoma:A systematic review[J].Life Sci,2017,179(1):80-87.
[4]Buendia MA,Neuveut C.Hepatocellular carcinoma[J].Cold Spring Harb Perspect Med,2015,5(2):a021444.
[5]Vallard A,Rancoule C,Guy JB,et al.Biomarkers of radiation-induced DNA repair processes[J].Bull Cancer,2017,104(11):981-987.
[6]Nickson CM,Moori P,Carter RJ,et al.Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity[J].Oncotarget,2017,8(18):29963-29975.
[7]Jin XL,Lian JR,Guan YH.Overexpression of long non-coding RNA MINCR contributes to progressive clinicopathological features and poor prognosis of human hepatocellular carcinoma[J].Eur Rev Med Pharmacol Sci,2018,22(23):8197-8202.
[8]Cui M,You L,Ren X,et al.Long non-coding RNA PVT1 and cancer[J].Bio Biophy Res Commu,2016,471(1):10-14.
[9]Iyer MK,Niknafs YS,Malik R,et al.The landscape of long non-coding RNAs in the human transcriptome[J].Nature Genetics,2015,47(3):199-208.
[10]Lu D,Luo P,Wang Q,et al.lncRNA PVT1 in cancer:A review and Meta analysis[J].Clinica Chimica Acta,2017,474(2017):1-7.
[11]WANG F,YANG F,YUAN JH,et al.Epigenetic mechanism of fetal liver-specific IncRNA regulation of liver development and hepatocarcinogenesis[C]//National Conference on Medical Genetics.2014.[王芳,杨富,袁继航,等.胎肝特异性IncRNA调控肝发育及肝癌发生的表观遗传学机制研究[C]//全国医学遗传学学术会议.2014.]
[12]ZHI XS,HUANG YY,ZI XY,et al.Progress in the role of long-chain non-coding RNA PVT1 in tumors[J].Journal of Xinxiang Medical College,2016,33(03):243-245,249.[职晓松,黄筱奕,訾晓渊,等.长链非编码RNA PVT1在肿瘤中的作用研究进展[J].新乡医学院学报,2016,33(03):243-245,249.]
[13]DING CF,WU J,YANG Z,et al.Clinical value of long-chain non-coding RNA PVT1 in predicting tumor recurrence after liver transplantation in liver cancer[C]//China Organ Transplantation Congress.2014.[丁超峰,吴健,杨喆,等.长链非编码RNA PVT1预测肝癌肝移植术后肿瘤复发的临床价值[C]//中国器官移植大会.2014.]
[14]Wang F,Yuan JH,Wang SB,et al.Oncofetal long non-coding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2[J].Hepatology,2014,60(4):1278-1290.
[15]ZHU YX,FU HW,LIN X,et al.Expression of hsa-circ-PVT1 in human hepatocellular carcinoma and its clinical significance[J].Medical Journal of Chinese People's Liberation,2018,43(3):211-216.[朱元鑫,付航玮,林夏,等.Hsa-circ-PVT1在肝细胞癌中的表达及意义[J].解放军医学杂志,2018,43(3):211-216.]
[16]ZHAO XX,WEN F,SUN HZ,et al.Progress in the role of radiation-sensitivity-regulated signaling pathways in cancer therapy[J].Modern Oncology,2018,26(10):1611-1614.[赵相轩,温锋,孙洪赞,等.放射线敏感性调节信号通路在癌症治疗中的作用研究进展[J].现代肿瘤医学,2018,26(10):1611-1614.]
[17]Zhang XW,Bu P,Liu L,et al.Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance[J].Biochemical & Biophysical Research Communications,2015,462(3):227-232.
[18]You L,Chang D,Du HZ,et al.Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells[J].Biochem Biophys Res Commun,2011,407(1):1-6.
[19]Fan H,Zhu JH,Yao XQ.Knockdown of long non-coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells[J].Molecular Medicine Reports,2018,17(6):8309-8315.
[20]Wu D,Li Y,Zhang H,et al.Knockdown of lncRNA PVT1 enhances radiosensitivity in non-small cell lung cancer by sponging miR-195[J].Cell Phys Biochem,2017,42(6):2453-2466.